Showing results (161-170 of 588) with videos related to
Sort By:
Pageof 59
JAMA Internal Medicine|December 26, 2012
Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysisSaurav Chatterjee, Jørn Wetterslev, Abhishek Sharma, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|September 10, 2011
Optimal medical therapy for coronary artery disease in 2011 - perspectives from the STICH TrialThomas F Whayne, Sibu P Saha, Karla Quevedo, et al.Cardiovascular & Hematological Disorders Drug Targets|July 5, 2014
Alogliptin; a review of a new dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type 2 diabetes mellitusSarmad Said, Azikiwe C Nwosu, Debabrata Mukherjee, et al.Inorganic Chemistry|September 11, 2025
[9-{2-(Dimethylamino)ethyl}fluorenyl] as a Ligand on Magnesium Leads to a THF Ring-Opening by the Fluorenyl MoietyChhotan Mandal, Subham Sarkar, Narottam Mukhopadhyay, et al.Inorganic Chemistry|July 23, 2025
Gauging the Intramolecular CAr-I Activation from Two Parallel Sets of MCl (M = Cu, Ag, Au) Adducts of an Iodobenzyl CAAC and Its NHC VariantSudip Baguli, Subham Sarkar, Soumajit Nath, et al.The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|August 12, 2024
Pericardial Decompression Syndrome: A Comprehensive Review of a Controversial EntityKaran Sarode, Amar Patel, Kedzie Arrington, et al.Cardiovascular & Hematological Disorders Drug Targets|November 3, 2023
Updates in the Pharmacotherapy of Pulmonary Hypertension in Patients with Heart Failure with Preserved Ejection FractionFernando Segovia, Hernando Garcia, Haider Alkhateeb, et al.Cardiovascular & Hematological Disorders Drug Targets|May 5, 2026
Microvascular Dysfunction in Ischemia with No Obstructive Coronary Arteries (INOCA): Pathophysiology, Diagnosis, and Emerging TherapiesSidhartha Senapati, Joel Shah, Lakshmi Kattamuri, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|February 5, 2020
Patent Foramen Ovale, the Role of Antiplatelet Therapy Alone or Anticoagulant Therapy Alone Versus Device Closure for Cryptogenic Stroke: A Review of the Literature and Current RecommendationsHarsha S Nagarajarao, Chandra P Ojha, Archana Kedar, et al.Current Vascular Pharmacology|July 25, 2021
Effect of Mineralocorticoid Receptor Antagonists in Heart Failure with Preserved Ejection Fraction and with Reduced Ejection Fraction - A Narrative ReviewAdriana Mares, Tayana Rodriguez, Abhizith Deoker, et al.Pageof 59